Ronald Peck is Chief Medical Officer at ARVINAS, INC. (ARVN). They have made 9 open-market trades across 1 company since 2020, most recently 2024-02-23.
CIK 0001783868
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARVN | 67,516 | $470K |
Shares reported on the most recent Form 4, priced at the 2024-02-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARVN | SELL | 2024-02-23 | 2024-02-27 | $47.05 | $160K | -1.1% | -13.2% | -25.9% |
| ARVN | SELL | 2023-08-11 | 2023-08-14 | $24.39 | $32K | +2.8% | +7.2% | -33.5% |
| ARVN | SELL | 2022-08-12 | 2022-08-16 | $68.99 | $87K | -13.2% | -4.1% | +2.1% |
| ARVN | SELL | 2022-08-12 | 2022-08-16 | $54.84 | $138K | -13.2% | -4.1% | +2.1% |
| ARVN | SELL | 2021-12-30 | 2022-01-04 | $80.61 | $3.2M | -13.9% | -13.6% | -6.4% |
| ARVN | SELL | 2021-08-12 | 2021-08-16 | $90.54 | $247K | -3.1% | +10.2% | -3.7% |
| ARVN | SELL | 2021-06-30 | 2021-07-02 | $76.69 | $1.5M | -7.8% | +23.1% | +3.6% |
| ARVN | SELL | 2021-02-16 | 2021-02-18 | $77.35 | $1.5M | -1.7% | -15.5% | -19.1% |
| ARVN | SELL | 2020-08-14 | 2020-08-18 | $27.46 | $34K | -9.3% | -0.3% | -5.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.